The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Abstract
Background— Atrial fibrillation (AF) is the most common cardiac dysrhythmia and a source of considerable morbidity and mortality, but lifetime risk for AF has not been estimated. Methods and Results— We included all participants in the Framingham Heart Study who were free of AF at index ages of 40 years and older. We estimated lifetime risks for AF (including atrial flutter) to age 95 years, with death free of AF as a competing event. We followed 3999 men and 4726 women from 1968 to 1999 (176 166 person-years); 936 participants had development of AF and 2621 died without prior AF. At age 40 years, lifetime risks for AF were 26.0% (95% CI, 24.0% to 27.0%) for men and 23.0% (21.0% to 24.0%) for women. Lifetime risks did not change substantially with increasing index age despite decreasing remaining years of life because AF incidence rose rapidly with advancing age. At age 80 years, lifetime risks for AF were 22.7% (20.1% to 24.1%) in men and 21.6% (19.3% to 22.7%) in women. In further analyses, counting only those who had development of AF without prior or concurrent congestive heart failure or myocardial infarction, lifetime risks for AF were approximately 16%. Conclusions— Lifetime risks for development of AF are 1 in 4 for men and women 40 years of age and older. Lifetime risks for AF are high (1 in 6), even in the absence of antecedent congestive heart failure or myocardial infarction. These substantial lifetime risks underscore the major public health burden posed by AF and the need for further investigation into predisposing conditions, preventive strategies, and more effective therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several regional studies suggest rising prevalence and incidence of AF.9–13”
From Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2014) · cites this paper as [9]
In the citing paper
“In North American populations, despite higher incidence of AF in men, lifetime risk of AF in women and men were similar owing to longer life expectancy for women.”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [30]
In the citing paper
“In the Rotterdam Study, the lifetime risks for women and men at age 55 years were 22.2% and 23.8%, respectively.30”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [30]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Self-citationImpact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Self-citationA comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Self-citationRisk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.13.1449 · Cited by 2,602
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Research works printed but not linked: 7
- 10.1161/circ.98.10.946 · DOI
- 10.1161/str.22.8.1866765 · DOI
- 10.1161/circ.96.7.2455 · DOI
- Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1989–1997) and Papanicolaou (1991–1997): behavioral risk factor surveillance system. MMWR CDC Surveill Summ. 1999; 48 (SS-6): 1–22.
- Beiser A, D’Agostino RB, Seshadri S, et al. Computing estimates of incidence, including lifetime risk. Stat Med. 2002; 19: 1495–1522.
- 10.1161/circ.103.5.769 · DOI
- 10.1001/archinte.1994.00420130036007 · DOI
Cited by
Sorted by citations
Items 901–1,000 of 1,001
Bouhenguel, R., & Mahgoub, I. (2012) · International Conference on Pervasive Computing Technologies for Healthcare · doi:10.4108/icst.pervasivehealth.2012.248670 · Cited by 15
Management of patients with acute atrial fibrillation in the ED
Conti, A., Taglia, B. D., Mariannini, Y., Pepe, G., Vanni, S., Grifoni, S., Abbate, R., Michelucci, A., Padeletti, L., & Gensini, G. F. (2010) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2009.05.005 · Cited by 17
To Screen or Not to Screen? Examining the Arguments Against Screening for Atrial Fibrillation
Neubeck, L., Orchard, J. J., Lowres, N., & Freedman, S. B. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.118 · Cited by 15
Morbidity and mortality with atrial fibrillation following colorectal surgery
Quinn, R., Mansfield, M., Brown, A., & Rangiah, D. S. (2018) · ANZ Journal of Surgery · doi:10.1111/ans.14484 · Cited by 15
Default Mode Network Disruption in Stroke-Free Patients with Atrial Fibrillation
Silva, D. S., Avelar, W. M., de Campos, B. M., Lino, A. P. B. L., Balthazar, M. L. F., Figueiredo, M. J. D. O., Cendes, F., & Coan, A. C. (2018) · Cerebrovascular Diseases · doi:10.1159/000486689 · Cited by 15
Veale, E. L., Stewart, A. J., Mathie, A. A., Lall, S. K., Rees-Roberts, M., Savickas, V., Bhamra, S. K., & Corlett, S. A. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-021121 · Cited by 15
Beri, A., & Punnam, S. R. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6122-y · Cited by 15
Saso, S., Vecht, J. A., Rao, C., Protopapas, A. D., Ashrafian, H., Leff, D. R., Darzi, A. W., & Athanasiou, T. (2009) · PubMed Central · Cited by 15
Lin, A. L., Allen, K. D., Gutierrez, J. A., Piccini, J. P., & Loring, Z. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.036899 · Cited by 14
Jones, A. E., McCarty, M. M., Brito, J. P., Noseworthy, P., Cavanaugh, K., Cameron, K. A., Barnes, G., Steinberg, B., Witt, D., Crossley, G., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.02.010 · Cited by 11
Contemporary management of pulmonary embolism: the answers to ten questions
Bounameaux, H. M. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02254.x · Cited by 14
Endo, D., Kato, T., Iwamura, T., Oishi, A., Yokoyama, Y., Kuwaki, K., Inaba, H., & Amano, A. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0915-x · Cited by 14
Ronco, F., Mazzone, P., Hosseinian, L., & Genovesi, S. (2017) · Cardiorenal Medicine · doi:10.1159/000470856 · Cited by 14
Lutsey, P. L., Norby, F. L., Zakai, N. A., MacLehose, R. F., Chen, L. Y., Shah, S., Datta, Y. H., & Alonso, Á. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1541445 · Cited by 15
Ricciardi, D., Arena, G., Verlato, R., Iacopino, S., Pieragnoli, P., Molon, G., Manfrin, M., Allocca, G., Cattafi, G., Sirico, G., et al. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00601-3 · Cited by 14
Ferguson, C., Inglis, S. C., Breen, P. P., Gargiulo, G. D., Byiers, V., Macdonald, P. S., & Hickman, L. (2020) · JMIR Aging · doi:10.2196/17299 · Cited by 15
Gawalko, M. M., Budnik, M., Uziębło‐Życzkowska, B., Krzesiński, P., Ścisło, P., Kochanowski, J., Jurek, A., Kiliszek, M., Gielerak, G. G., Filipiak, K. J., et al. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13609 · Cited by 14
Malaspina, D., Brasca, F. M. A., Iacopino, S., Arena, G., Molon, G., Pieragnoli, P., Tondo, C., Manfrin, M., Rovaris, G., Verlato, R., et al. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14149 · Cited by 14
Munir, M. B., Khan, M. Z., Darden, D. J., Asad, Z. U. A., Choubdar, P. A., Din, M. T. U., Osman, M., Singh, G. D., Srivatsa, U. N., Balla, S., et al. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01266-1 · Cited by 14
Martı́n, A., Lozano, I. F., Puig, B. C.-V., Tercedor, L., del Arco, C., Ynsaurriaga, F. A., Méndez, C. S., & Girbau, L. M. (2012) · Emergencias · Cited by 14
Giannakidis, A., Nyktari, E. G., Keegan, J., Pierce, I., Horduna, I., Haldar, S., Pennell, D. J., Mohiaddin, R. H., Wong, T., & Firmin, D. N. (2015) · BioMedical Engineering OnLine · doi:10.1186/s12938-015-0083-8 · Cited by 14
Steinberg, B. A., Broderick, S. H., Lópes, R. D., Shaw, L. K., Thomas, K. L., DeWald, T. A., Daubert, J. P., Peterson, E. D., Granger, C. B., & Piccini, J. P. (2014) · EP Europace · doi:10.1093/europace/euu077 · Cited by 14
Evaluación de riesgo tromboembólico y hemorrágico de los pacientes con fibrilación auricular
Soldevila, J. G., Ruiz, M. D. M., Robert, I. D., Tornos, P., & Martínez‐Rubio, A. (2013) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(13)70053-0 · Cited by 14
Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation
Swaans, M. J., Post, M. C., Rensing, B. J. W. M., & Boersma, L. V. A. (2012) · Netherlands Heart Journal · doi:10.1007/s12471-011-0236-8 · Cited by 14
Edoxaban (Savaysa): A Factor Xa Inhibitor.
Chan, L., & Pisano, M. (2015) · Europe PMC (PubMed Central) · Cited by 14
van den Bruck, J., Sultan, A., Lüker, J., Thomas, D., Willems, S., Weinmann, K., Kuniss, M., Hochadel, M., Senges, J., Andresen, D., et al. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1356-6 · Cited by 14
Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation
Krisai, P., Blum, S., Aeschbacher, S., Beer, J. H., Moschovitis, G., Witassek, F., Kobza, R., Rodondi, N., Moutzouri, E., Mahmood, A., et al. (2020) · Heart · doi:10.1136/heartjnl-2019-316314 · Cited by 14
Surgical and minimally invasive ablation for atrial fibrillation
Damiano, R. J., & Voeller, R. K. (2006) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-006-0041-7 · Cited by 14
Managing atrial fibrillation in the CRT patient: Controversy or consensus?
Upadhyay, G. A., & Steinberg, J. S. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.04.030 · Cited by 14
Stretch-induced alterations of human Kir2.1 channel currents
He, Y., Xiao, J., Yang, Y., Zhou, Q., Zhang, Z., Pan, Q., Liu, Y., & Chen, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.049 · Cited by 14
Catheter Ablation of Atrial Fibrillation
Callahan, T. D., Biase, L. D., Horton, R., Sánchez, J., Gallinghouse, J. G., & Natale, A. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.09.004 · Cited by 14
Atrial Fibrillation—A New Cardiac Channelopathy
Otway, R., Vandenberg, J. I., & Fatkin, D. (2007) · Heart Lung and Circulation · doi:10.1016/j.hlc.2007.07.003 · Cited by 13
Cost-of-illness studies of atrial fibrillation: methodological considerations
Becker, C. (2014) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2014.940904 · Cited by 13
Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation
Peyrol, M., Sbragia, P., Bonello, L., Lévy, S., & Paganelli, F. F. (2011) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2011.07.003 · Cited by 13
The Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation
Ha, A. C. T., & Healey, J. S. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.06.001 · Cited by 13
Gersh, B. J., Freedman, J. E., & Granger, C. B. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.01.001 · Cited by 13
Kleyko, D. V., Osipov, E., & Wiklund, U. (2020) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ab6e1e · Cited by 13
Gender differences in stroke risk factors
Maksimova, M. Y., & Айрапетова, А. С. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201911912258 · Cited by 18
Jiang, J., Gu, X. Q., Cheng, C., Li, H., Sun, X., Duan, R.-Y., Zhu, Y., Sun, L., Chen, F., Bao, Z.-Y., et al. (2020) · JMIR mhealth and uhealth · doi:10.2196/22137 · Cited by 13
Cavallari, I., & Patti, G. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa147 · Cited by 13
Gangani, K., Fong, H. K., Faisaluddin, M., Lodhi, M. U., Manaktala, P. S., Sadolikar, A., Shah, V. P., Gandhi, Z., Hassan, F. A., Savani, S., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12482 · Cited by 13
Ke, Z.-P., Zhang, G.-F., Guo, Y.-H., Sun, Y.-M., Wang, J., Li, N., Qiu, X.-B., Xu, Y.-J., & Yang, Y.-Q. (2022) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2021-0378 · Cited by 13
Munir, M. B., Khan, M. Z., Darden, D. J., Asad, Z. U. A., Osman, M., Singh, G. D., Srivatsa, U. N., Han, F. T., Reeves, R. R., & Hsu, J. C. (2022) · EP Europace · doi:10.1093/europace/euac043 · Cited by 13
Deshpande, S., Catanzaro, J. N., & Wann, S. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2013.10.006 · Cited by 13
Patel, S., French, A., Mathias, H., Lyen, S. M., Hamilton, M. C. K., & Manghat, N. E. (2013) · Clinical Radiology · doi:10.1016/j.crad.2013.02.005 · Cited by 14
Epidemiología de la fibrilación auricular y comorbilidades asociadas
García‐Seara, J., & González‐Juanatey, J. R. (2012) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(12)70045-6 · Cited by 13
Leal, S., Moreno, R., Almeida, M., Silva, J. A., & López-Sendón, J. L. (2012) · Current Cardiology Reviews · doi:10.2174/157340312801215827 · Cited by 13
Sidorova, T. N., Mace, L. C., Wells, K. S., Yermalitskaya, L. V., Su, P.-F., Shyr, Y., Byrne, J. G., Petracek, M. R., Greelish, J. P., Hoff, S. J., et al. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414535782 · Cited by 13
Avances en la prevención de la isquemia cerebral por fibrilación auricular
Núñez, A. G. (2010) · Neurología · doi:10.1016/j.nrl.2010.03.008 · Cited by 13
Amiodarone attenuates apoptosis, but induces phospholipidosis in rat alveolar epithelial cells.
Kapatou, E., Skyrlas, A., Agelaki, M. G., Pantos, C. I., Kolettis, T. M., & Malamou‐Mitsi, V. (2010) · PubMed · Cited by 13
Ekblad, H., Malm, D., Fridlund, B., Conlon, L., & Rönning, H. (2014) · The Open Nursing Journal · doi:10.2174/1874434601408010048 · Cited by 13
Use of Intracardiac Echocardiography During Atrial Fibrillation Ablation to Avoid Complications
Lin, D., & Callans, D. J. (2015) · Future Cardiology · doi:10.2217/fca.15.64 · Cited by 13
Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation
Femia, G., Fetahovic, T., Shetty, P., & Lee, A. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.06.726 · Cited by 13
Risk factors for heart failure hospitalizations among patients with atrial fibrillation
Eggimann, L., Blum, S., Aeschbacher, S., Reusser, A., Ammann, P., Erné, P., Moschovitis, G., Valentino, M. D., Shah, D. C., Schläpfer, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191736 · Cited by 13
Sympathetic responses induced by radiofrequency catheter ablation of atrial fibrillation
Cui, J. G., Gonzalez, M. D., Blaha, C., Hill, A., & Sinoway, L. I. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00470.2018 · Cited by 13
Daniels, L. B., Antonini, P., Marino, R., Rizzo, M., Navarin, S., Lucibello, S. G., Maisel, A. S., Pizza, V., Brenner, D. A., Jeste, D. V., et al. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000910 · Cited by 13
Shiyovich, A., Chodick, G., Azani, L., Tirosh, M., Shuvy, M., Pereg, D., Katz, A., & Minha, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247097 · Cited by 12
Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation
van der Heyden, M. A. G., & Jespersen, T. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.026 · Cited by 13
Kik, C., Mouws, E. M. J. P., Bogers, A. J. J. C., & de Groot, N. M. S. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1340156 · Cited by 13
Robotic and magnetic navigation for atrial fibrillation ablation. How and why?
Pappone, C., Augello, G., Gugliotta, F., & Santinelli, V. (2007) · Expert Review of Medical Devices · doi:10.1586/17434440.4.6.885 · Cited by 13
Predicting Incident Atrial Fibrillation
Marcus, G. M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.426 · Cited by 13
Is altered atrial microRNA-ome a critical contributor to the pathophysiology of atrial fibrillation?
Dobrev, D. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0284-2 · Cited by 13
Modulation of SK Channels: Insight Into Therapeutics of Atrial Fibrillation
Qi, M., Qian, L., & Wang, R. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.01.009 · Cited by 12
Kistler, P. M., Sanders, P., Amarena, J., Bain, C., Chia, K. K. M., Choo, W. K., Eslick, A., Hall, T. L., Hopper, I., Kotschet, E., et al. (2024) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.12.024 · Cited by 12
Gomes, E. R., Campos, R., Morais, R., & Fernandes, M. (2015) · Acta Médica Portuguesa · doi:10.20344/amp.5503 · Cited by 12
Cardiac Procedures to Prevent Stroke: Patent Foramen Ovale Closure/Left Atrial Appendage Occlusion
Freixa, X., Arzamendi, D., Tzikas, A., Noble, S., Basmadjian, A., Garceau, P., & Ibrahim, R. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.11.008 · Cited by 12
DiNicolantonio, J. J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.671809 · Cited by 12
Atrial fibrillation and the athletic heart
Redpath, C. J., & Backx, P. H. (2014) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000130 · Cited by 12
Blandino, A., Bianchi, F., Biondi‐Zoccai, G., Grossi, S., Conte, M. R., Rametta, F., & Gaïta, F. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0141-6 · Cited by 12
Sasaki, K., Haga, M., Bao, S., Sato, H., Saiki, Y., & Maruyama, R. (2017) · Gerontology and Geriatric Medicine · doi:10.1177/2333721417708071 · Cited by 12
Atrial fibrillation ablation alone or atrial fibrillation ablation plus an antiarrhythmic drug?
Pokorney, S. D., & Daubert, J. P. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy120 · Cited by 12
Screening for undiagnosed atrial fibrillation
Sandhu, R., & Healey, J. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1496018 · Cited by 11
Rosenfeld, L. E., Amin, A., Hsu, J. C., Oxner, A. Z., Hills, M. T., & Frankel, D. S. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.04.007 · Cited by 12
da Costa, J. M., Marcolino, M. S., Torres, H. D. C., de Resende, R. E., de Souza, R. P., Barbosa, H. C., Ribeiro, D. D., & Martins, M. A. P. (2019) · Medicine · doi:10.1097/md.0000000000015829 · Cited by 12
Moghaddasi, H., Hendriks, R. C., van der Veen, A.-J., de Groot, N. M. S., & Hunyadi, B. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105270 · Cited by 12
PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation
Ezeani, M., & Prabhu, S. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04526-w · Cited by 11
Zhai, C., Cong, H., Liu, Y., Zhang, Y., Liu, X., Zhang, H., & Ren, Z. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0044-y · Cited by 12
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
Turpie, A. G. G. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s30159 · Cited by 12
Schmiegelow, M., Pedersen, O. D., Køber, L., Seibæk, M., Abildstrom, S. Z., & Torp-Pedersen, C. T. (2011) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-11-19 · Cited by 12
Gastrointestinal comorbidities associated with atrial fibrillation
Laliberté, F., Moore, Y., Dea, K., LaMori, J. C., Mody, S. H., Jones, J. L., Arledge, M. D., Damaraju, C. V., Schein, J. R., & Lefèbvre, P. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-603 · Cited by 12
Stroke Prevention in Atrial Fibrillation: Where are We Now?
Ahmad, Y., & Lip, G. Y. H. (2012) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s8976 · Cited by 12
Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients
Gürdoğan, M., Arı, H., Tenekecioğlu, E., Arı, S., Bozat, T., Koca, V., & Melek, M. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160013 · Cited by 12
Watanabe, E., Yamamoto, M., Kodama, I., Inoue, H., Atarashi, H., Okumura, K., Yamashita, T., Lip, G. Y. H., Kodani, E., Okuyama, Y., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.008 · Cited by 12
Stroke prevention in atrial fibrillation
Mohammed, I., Mohmand-Borkowski, A., Burke, J. F., & Kowey, P. R. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834f2336 · Cited by 12
ANCZYKOWSKI, J., Willems, S., Hoffmann, B. A., Meinertz, T., Blankenberg, S., & Patten, M. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13025 · Cited by 12
Association of cardiac cachexia and atrial fibrillation in heart failure patients
Arámbula-Garza, E., Castillo‐Martínez, L., González‐Islas, D., Orea‐Tejeda, A., Santellano-Juárez, B., Keirns-Davies, C., Peláez-Hernández, V., Sánchez‐Santillán, R., Pineda-Juárez, J. A., Cintora-Martínez, C., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.318 · Cited by 12
Yavuz, B., Ata, N., Oto, E., Katircioglu-Öztürk, D., Aytemir, K., Evranos, B., Koselerli, R., Ertugay, E., BÜrkan, A., Ertugay, E., et al. (2017) · EP Europace · doi:10.1093/europace/euw385 · Cited by 12
Alagiakrishnan, K., Banach, M., Mah, D., Ahmed, A., & Aronow, W. S. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.07.021 · Cited by 12
Ma, G., Wu, X., Zeng, L., Jin, J., Liu, X., Zhang, J., & Zhang, L. (2019) · Cardiology Research and Practice · doi:10.1155/2019/8271871 · Cited by 12
Lernfelt, G., Mandalenakis, Z., Hornestam, B., Lernfelt, B., Rosengren, A., Sundh, V., & Hansson, P. (2020) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2020.1729399 · Cited by 11
New concepts for old drugs to maintain sinus rhythm in patients with atrial fibrillation
Kirchhof, P. F., & BREITHARDT, G. E. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.01.023 · Cited by 12
Management of Atrial Fibrillation
Zamani, P. L., & Verdino, R. J. (2014) · Journal of Intensive Care Medicine · doi:10.1177/0885066614534603 · Cited by 12
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Swaans, M. J., Alipour, A., Rensing, B. J. W. M., Post, M. C., & Boersma, L. V. A. (2013) · Journal of Visualized Experiments · doi:10.3791/3818 · Cited by 12
Pharmacological therapy of atrial fibrillation
Patton, K. K., & Page, R. L. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.2.169 · Cited by 12
Atrial Fibrillation and Flutter
Brady, P. A., & Gersh, B. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_95 · Cited by 12
Makati, K. J., Alsheikh-Ali, A. A. A., Garlitski, A. C., Link, M. S., Homoud, M. K., Weinstock, J., & Estes, N. A. M. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9256-8 · Cited by 12
Raviele, A. (2006) · Springer eBooks · doi:10.1007/88-470-0371-7 · Cited by 12
Brachmann, J., VOGTMANN, T., Hummel, J. D., Swarup, V., Wilber, D. J., Rapkin, J. S., Shpun, S., Sarver, A. E., & Szili‐Törok, T. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.121.022346 · Cited by 12
Aras, D., Birgül, E., Görenek, B., Gürkaş, E., Özdemi̇r, A. Ö., Topçuoğlu, M. A., Yavuz, E., & Zoghi, M. (2022) · The Anatolian Journal of Cardiology · doi:10.5152/anatoljcardiol.2022.1689 · Cited by 11
Atrial fibrillation and survival on a medical intensive care unit
Rottmann, F. A., Abraham, H., Welte, T., Westermann, L., Bemtgen, X., Gauchel, N., Supady, A., Wengenmayer, T., & Staudacher, D. L. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131673 · Cited by 11
Metadata
- Authors
- Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., D’Agostino, R. B., Massaro, J. M., Beiser, A., Wolf, P. A., & Benjamin, E. J.
- Affiliations
- From the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill (D.M.L.-J.); the National Heart, Lung, and Blood Institute’s Framingham Heart Study, National Institutes of Health, Framingham, Mass (all authors); the Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (T.J.W.); the Department of Epidemiology and Preventive Medicine (M.G.L., D.L., R.B.D., R.S.V., E.J.B.), Cardiology Department (R.S.V., E.J.B.), and...
- Northwestern University (US)
- Boston University (US)
- ORCID
- Venue
- Circulation
- Published
- 2004-08-31
- Volume
- 110
- Issue
- 9
- Pages
- 1042-1046
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2137434301
- Cited by
- 2,041
- References
- 41
- Citations by year
- 2026: 43 · 2025: 53 · 2024: 71 · 2023: 71 · 2022: 84 · 2021: 102 · 2020: 111 · 2019: 101 · 2018: 124 · 2017: 136 · 2016: 119 · 2015: 130 · 2014: 129 · 2013: 170 · 2012: 145
- FWCI
- 28.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (K23 HL04253, N01‐HC25195, K23HL004253)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- atrial fibrillation, lifetime risk, atrial flutter, Framingham Heart Study, competing risks, congestive heart failure, myocardial infarction, sex differences, public health burden, cardiac arrhythmias
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Atrial Fibrillation, Atrial Flutter, Electrocardiography, Female, Follow-Up Studies, Heart Failure, Humans, Hypertension, Male, Middle Aged, Myocardial Infarction, Risk, Risk Factors, United States, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review